To expand the limits of transdermal drug delivery, developers are employing energy sources such as ultrasound, heat and electrical current to affect active transport through the skin. These techniques can increase the upper molecular size limit dramatically, opening up a host of opportunities for transdermal delivery. Iontophoresis devices with ease-of-use features have the potential to address the needs of an aging population for user-friendly delivery and are positioned to make a significant impact in selected therapeutic areas. This report includes analysis of iontophoretic transdermal technologies, market and regulatory factors, product evaluations, and profiles of leading sector participants.
What Your Will Learn
• What are the approved iontophoresis products for transdermal drug delivery? Who markets them? What is there market position?
• What iontophoresis devices are currently in development? What are their prospects? and assesses the market potential for existing and probable future products
• What are the key iontophoresis device design elements, technologies and operational factors?
• What are the important therapeutic sectors and market segments for iontophoresis?
• What does the market look like today? Who are the market leaders? What will it be in 2020?
• Who are the key players in this market? Their product development activities & business strategies?
• What is the importance of pharma-device alliances and design partnerships on iontophoresis delivery products
• What is the impact of economic, technology, and regulatory factors on transdermal device markets?
Iontophoresis Systems for Transdermal Drug Delivery – Summary of Contents
Transdermal Drug Delivery Dynamics
The Trend toward Self-Care
Iontophoresis Device Design Factors
Human Engineering/Ease of Use
Dosing and Rate Factors
Power Requirements & Battery Technology
Key Therapeutic Application Segment Analysis
Iontophoresis Product Assessments and Forecasts
Disposable Single-use products
Discrete Controller Devices
Patient Compliance Factors
Contract Design and Manufacturing
Clinical Trial Process
Shifting Patient Demographics